Autologous cytokine‐induced killer (<scp>CIK</scp>) cells enhance the clinical response to <scp>PD‐1</scp> blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary studyYing Han, Xiubao Ren, Ting Liu et al.|Thoracic Cancer|2020Cited by 24